86 / 89
86
Sclerosis Study Group of the Italian Society of
Rheumatology (SIR-GSSSc). Systemic sclerosis:
demographic, clinical, and serologic features
and survival in 1,012 Italian patients. Medicine
2002;81:139–53.
124.
Scussel-Lonzetti L, Joyal F, Raynauld JP,
Roussin A, Rich E, Goulet JR, et al. Predicting
mortality in systemic sclerosis: analysis of a
cohort of 309 French Canadian patients with
emphasis on features at diagnosis as predictive
factors for survival. Medicine 2002;81:154–67.
125.
Ioannidis JP, Vlachoyiannopoulos PG, Haidich
AB, Medsger TA Jr, Lucas M, Michet CJ, et al.
Mortality in systemic sclerosis: an international
meta-analysis of individual patient data. Am J
Med 2005;118:2–10.
126.
Sampaio-Barros
PD,
Bortoluzzo
AB,
Marangoni RG, Rocha LF, Del Rio AP, Samara
AM, et al. Survival, causes of death, and
prognostic factors in systemic sclerosis:
analysis of 947 Brazilian patients. J Rheumatol
2012;39:1971-8.
127.
Montisci R, Vacca A, Garau P, Colonna P,
Ruscazio M, Passiu G, et al. Detection of early
impairment of coronary flow reserve in
patients with systemic sclerosis. Ann Rheum
Dis 2003;62:890-3.
128.
Sulli A, Ghio M, Bezante GP, Deferrari L,
Craviotto C, Sebastiani V, et al. Blunted
coronary flow reserve in systemic sclerosis.
Rheumatology (Oxford) 2004;43:505–9.